---
title: "Sensata Technologies Introduces Active + Passive PyroFuse to Advance High-Voltage Safety"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291283747.md"
description: "Sensata, a company based in Swindon, United Kingdom, has introduced a new product called the Active+ Passive PyroFuse. This innovation combines active and passive fault interruption mechanisms to streamline high-voltage protection in electrified systems. The Active+ Passive PyroFuse aims to simplify the process of protecting against faults in electric vehicles (EVs) and similar systems. This development is expected to play a significant role in enhancing safety measures in high-voltage environments."
datetime: "2026-06-30T12:09:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291283747.md)
  - [en](https://longbridge.com/en/news/291283747.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291283747.md)
---

# Sensata Technologies Introduces Active + Passive PyroFuse to Advance High-Voltage Safety

Sensata, a company based in Swindon, United Kingdom, has introduced a new product called the Active+ Passive PyroFuse. This innovation combines active and passive fault interruption mechanisms to streamline high-voltage protection in electrified systems. The Active+ Passive PyroFuse aims to simplify the process of protecting against faults in electric vehicles (EVs) and similar systems. This development is expected to play a significant role in enhancing safety measures in high-voltage environments.

### Related Stocks

- [ST.US](https://longbridge.com/en/quote/ST.US.md)

## Related News & Research

- [Sensata Technologies Q2 results beat estimates on revenue growth, margin gains](https://longbridge.com/en/news/294255094.md)
- [Sensata Technologies Holding plc Stock 12‑Month Price Target Raised to $53.1, Implies 15% Upside](https://longbridge.com/en/news/294319131.md)
- [GOSS: NDA for seralutinib in PAH on track for September 2026, with global rights and reduced debt](https://longbridge.com/en/news/293945384.md)
- [Inhibikase wins FDA orphan drug designation for IKT-001 in PAH](https://longbridge.com/en/news/293613509.md)
- [ELEKTROS Reports Strategic Interest in Proprietary EV Charging Patent | ELEK Stock News](https://longbridge.com/en/news/294244818.md)